Your Global Leader in Stem Cell Market Research
Stem cell therapy continues to rally worldwide recognition as governments fund research and expand access. This once-controversial therapy is fast becoming one of medicine’s most exciting technologies. From FDA-approved therapies to in-house, physician-initiated autologous techniques, stem cell technology continues to evolve. 2025 promises to be an exciting year for the stem cell market.
Here’s everything you need to know about the future of this revolutionary therapy. [Read more…]
Few weight-loss solutions have attracted public attention as quickly as GLP-1 medications. You might’ve heard about Wegovy, Ozempic, and Zepbound, which help many people experience significant weight loss. [Read more…]
Since the discovery of mesenchymal stem cells (MSCs) by Friedenstein and his colleagues in 1976, MSCs have become one of the fastest growing areas of stem cell research. They are more frequently cited than any other stem cell type within the scientific literature, Google Trend data shows MSC searches to be approximately twice as common as the next most common adult stem cell type, and at least  1,753 MSC clinical trials have been pursued worldwide. There have also been an absolutely astounding 107,232 scientific articles published about MSCs to date. [Read more…]
Many experts have spoken about the power of stem cells and their ability to alter the field of healthcare forever, including these top stem cell quotes of all-time. With exponential progress occurring in the field, stem cells are ushering in an age of regenerative medicine that will transform healthcare in ways that are now inconceivable.
In coming decades, stem cells will be reversing diseases ranging from Alzheimer’s to autism, re-growing organs and tissues, and potentially allowing the first humans to reach the age of 200.
Cord blood and tissue banking is the collection and preservation of the valuable cells within the umbilical cord of a newborn for future medical use. For both therapeutic and financial reasons, the cord blood industry has been witnessing record levels of M&A activity in recent years. Today, more than 70% of the global cord blood market is controlled by the world’s ten largest cord blood banking operators. [Read more…]
